Shopping Cart
- Remove All
- Your shopping cart is currently empty
GEMSA is a potent inhibitor of enkephalin convertase (Ki = 8.8 nM) with analgesic effects[1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $458 | 35 days |
Description | GEMSA is a potent inhibitor of enkephalin convertase (Ki = 8.8 nM) with analgesic effects[1]. |
In vitro | GEMSA effectively inhibits the activation of TAFI and porcine CBB, along with preventing the extended lysis time observed in recombinant BAP without causing the lysis of APC fibronectin. Additionally, GEMSA demonstrates inhibition of the increased lysis time associated with porcine CPB, TAFI, and recombinant BAP, APC, exhibiting EC50 values of 0.34 μM, 100 μM, 115 μM, and 90 μM, respectively. |
In vivo | GEMSA administered intracerebroventricularly (ICV) at a dose of 0.1μg/mg every 3 days results in a 75% elevation in both hypothalamic luteinizing hormone-releasing hormone and serum luteinizing hormone levels, alongside a 60% reduction in serum prolactin concentrations in rats [3]. |
Molecular Weight | 235.26 |
Formula | C7H13N3O4S |
Cas No. | 77482-44-1 |
Relative Density. | 1.59g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.